期刊文献+

卵巢癌肿瘤干细胞标记物研究的新进展 被引量:1

Advances of Biomarkers of Ovarian Cancer Stem Cells
下载PDF
导出
摘要 卵巢癌是女性生殖系统一种常见的恶性肿瘤,一般在治疗的初始阶段患者能够获得较好的疗效,但在治疗后期,部分患者会复发,这与卵巢癌干细胞之间有着密切的联系。肿瘤干细胞在肿瘤组织中数量稀少,对常规化疗耐药,能够形成新的肿瘤细胞,是导致肿瘤复发的根源之一。近年来,人们针对卵巢癌干细胞的鉴定与分离开展了大量的研究,分析了该类细胞特征性的标志物。目前已被证实的卵巢癌干细胞标志物主要有CD133、乙醛脱氢酶、CD44、CD117、CD24等。本文旨在对这些卵巢癌干细胞的标志物的相关研究及其在卵巢癌的诊断与治疗中的作用进行综述。 Ovarian cancer is a common malignant tumor in the reproductive system of women, for which at the time of initial treatment we can obtain complete chnical remission. However, some will relapse in the later stage of the disease. This phenomenon may be correlated to the cancer stem cell. The cancer stem cell possesses several properties, which includes rare cells, resistance to chemotherapy, ability to arise the daughter cells. It is one of the roots of neoplasm recurrence. In recent years, a huge amount of study has been carried out on the method of isolation and identification of the cancer stem cells, as well as on the markers of such kind of cells. This review will focus on the biomarkers of the ovarian cancer stem cell and their application in the diagnosis and therapy of the disease.
出处 《肿瘤药学》 CAS 2013年第3期172-175,共4页 Anti-Tumor Pharmacy
基金 国家自然科学基金项目资助(81201730) 中国博士后科学基金面上资助(2012MS21565) 湖南省科学技术厅科技计划项目(2010FJ3078) 湖南省卫生厅科研基金项目(132011-088)
关键词 肿瘤干细胞 卵巢癌 标志物 Cancer stem cells Ovarian cancer Biomarker
  • 相关文献

参考文献19

  • 1Szotek PP,Pieretti-Vanmarcke R,Masiakos PT. Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness[J].{H}Proceedings of the National Academy of Sciences(USA),2006,(30):11154-11159.
  • 2Zeimet AG,Reimer D,Sopper S. Ovarian can-cer stem cells[J].{H}NEOPLASMA,2012,(06):747-755.
  • 3Bapat SA. Human ovarian cancer stem cells[J].Reproduc-tion,2010,(01):33-41.
  • 4Kwon MJ,Shin YK. Regulation of Ovarian Cancer Stem Cells or Tumor-Initiating Cells[J].{H}INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES,2013,(04):6624-6648.
  • 5Stewart JM,Shaw PA,Gedye C. Phenotypic hetero-geneity and instability of human ovarian tumor-initiating cells[J].{H}Proceedings of the National Academy of Sciences(USA),2011,(16):6468-6473.
  • 6Hirohashi Y,Torigoe T,Inoda S. Immune response against tumor antigens expressed on human cancer stem-like cells/tumor-initiating cells[J].{H}Immunotherapy,2010,(02):201-211.
  • 7Tu LC,Foltz G,Lin E. Targeting stem cells-clinical implications for cancer therapy[J].{H}Current Stem Cell Research & Therapy,2009,(02):147-153.
  • 8Ahmed N,Abubaker K,Findlay J. Cancerous ovarian stem cells:obscure targets for therapy but relevant to che-moresistance[J].{H}Journal of Cellular Biochemistry,2013,(01):21-34.
  • 9Levanon K,Ng V,Piao HY. Primary ex-vivo cul-tures of human fallopian tube epithelium as a model for serous ovarian carcinogenesis[J].{H}ONCOGENE,2010,(08):1103-1113.
  • 10Levanon K,Crum C,Drapkin R. New insights into the pathogenesis of serous ovarian cancer and its clinical impact[J].{H}Journal of Clinical Oncology,2008,(32):5284-5293.

同被引文献9

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部